Literature DB >> 28901084

[Analysis and exploration on adverse reactions of four kinds of andrographolide injections].

Dong Xiang1, Meng-Die Wang1, Wen-Qing Wang1, Chun-Yang Shi1, Xue-Jia Xie1, Jian-Guo Fang1.   

Abstract

Concerned literature on four kinds of andrographolide injections in recent 15 years were searched in CNKI, Wanfang and VIP databases. The adverse drug reaction(ADR) cases of Chuanhuning, Yanhuning, Xiyanping and Lianbizhi injections were classified and analyzed statistically, including a total of 194 articles and 3 479 cases. The ADR clinical characteristics and occurrence regularity of these four andrographolide injections were analyzed and compared from the gender, age, primary disease, emergence time of ADR, clinical manifestation, allergy history, dosage, prognosis and combined medication of the patients. It is useful to provide valuable references for rational use of these andrographolide injections in clinical practice. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  adverse reactions ; andrographolide ; safety study ; traditional Chinese medicine injections

Mesh:

Substances:

Year:  2016        PMID: 28901084     DOI: 10.4268/cjcmm20161229

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

Review 1.  Normative Application of Xiyanping Injection: A Systematic Review of Adverse Case Reports.

Authors:  Shiqi Chen; Joey S W Kwong; Rui Zheng; Yanping Wang; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-15       Impact factor: 2.629

Review 2.  Adverse Effects of Andrographolide Derivative Medications Compared to the Safe use of Herbal Preparations of Andrographis paniculata: Results of a Systematic Review and Meta-Analysis of Clinical Studies.

Authors:  Ya-Xi Shang; Chen Shen; Trine Stub; Si-Jia Zhu; Shu-Yu Qiao; Yu-Qi Li; Rui-Ting Wang; Jing Li; Jian-Ping Liu
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.